These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12502368)
1. Studies on the mechanisms of activation of indolequinone phosphoramidate prodrugs. Hernick M; Borch RF J Med Chem; 2003 Jan; 46(1):148-54. PubMed ID: 12502368 [TBL] [Abstract][Full Text] [Related]
3. N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization. Sykes BM; Atwell GJ; Hogg A; Wilson WR; O'Connor CJ; Denny WA J Med Chem; 1999 Feb; 42(3):346-55. PubMed ID: 9986704 [TBL] [Abstract][Full Text] [Related]
4. Design of anticancer prodrugs for reductive activation. Chen Y; Hu L Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase. Hernick M; Flader C; Borch RF J Med Chem; 2002 Aug; 45(16):3540-8. PubMed ID: 12139465 [TBL] [Abstract][Full Text] [Related]
6. Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase. Helsby NA; Atwell GJ; Yang S; Palmer BD; Anderson RF; Pullen SM; Ferry DM; Hogg A; Wilson WR; Denny WA J Med Chem; 2004 Jun; 47(12):3295-307. PubMed ID: 15163209 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units. Tanabe K; Sugiura M; Ito T; Nishimoto S Bioorg Med Chem; 2012 Sep; 20(17):5164-8. PubMed ID: 22847019 [TBL] [Abstract][Full Text] [Related]
8. Cyclopropyl indolequinones: mechanistic probes for bioreductive anticancer drug action. Moody CJ; Norton CL; Slawin AM; Taylor S Anticancer Drug Des; 1998 Sep; 13(6):611-34. PubMed ID: 9755721 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug. Boutselis IG; Yu X; Zhang ZY; Borch RF J Med Chem; 2007 Feb; 50(4):856-64. PubMed ID: 17249650 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductase. Atwell GJ; Boyd M; Palmer BD; Anderson RF; Pullen SM; Wilson WR; Denny WA Anticancer Drug Des; 1996 Oct; 11(7):553-67. PubMed ID: 8921936 [TBL] [Abstract][Full Text] [Related]
11. Radiation-activated prodrugs as hypoxia-selective cytotoxins: model studies with nitroarylmethyl quaternary salts. Wilson WR; Tercel M; Anderson RF; Denny WA Anticancer Drug Des; 1998 Sep; 13(6):663-85. PubMed ID: 9755724 [TBL] [Abstract][Full Text] [Related]
13. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines. Jain M; Fan J; Baturay NZ; Kwon CH J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662 [TBL] [Abstract][Full Text] [Related]
14. Hydrolytic reactions of thymidine 5'-o-phenyl-N-alkylphosphoramidates, models of nucleoside 5'-monophosphate prodrugs. Ora M; Ojanperä J; Lönnberg H Chemistry; 2007; 13(30):8591-9. PubMed ID: 17654626 [TBL] [Abstract][Full Text] [Related]
15. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form. Johansson E; Parkinson GN; Denny WA; Neidle S J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054 [TBL] [Abstract][Full Text] [Related]
16. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs. Duan JX; Jiao H; Kaizerman J; Stanton T; Evans JW; Lan L; Lorente G; Banica M; Jung D; Wang J; Ma H; Li X; Yang Z; Hoffman RM; Ammons WS; Hart CP; Matteucci M J Med Chem; 2008 Apr; 51(8):2412-20. PubMed ID: 18257544 [TBL] [Abstract][Full Text] [Related]
17. Sulfonyl-containing nucleoside phosphotriesters and phosphoramidates as novel anticancer prodrugs of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP). Sun YW; Chen KM; Kwon CH Mol Pharm; 2006; 3(2):161-73. PubMed ID: 16579645 [TBL] [Abstract][Full Text] [Related]